InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.39
(
0.67%
)
US TECH 100
18,352.80
(
1.14%
)
Dow Jones
39,151.30
(
0.22%
)
Brent Oil
81.78
(
0.57%
)
Bitcoin
68,183.02
(
0.38%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: None

Thursday, 07/24/2014 7:17:00 PM

Thursday, July 24, 2014 7:17:00 PM

Post# of 80490
CAR-T is the hottest new direction for cancer treatment. However, it comes with all sorts of nasty side effects. Therefore pharmas are looking for an on/off switch to keep it attacking the cancer only.

Ziopharm and Intrexon have an oar in the water.

http://www.investorvillage.com/smbd.asp?mb=16353&mn=7167&pt=msg&mid=14027003

Ariad and Bellicum are also in the game.

http://www.bellicum.com/press-releases/first-cancer-trial-launched-using-car-t-cells-engineered-with-bellicums-safety-switch/

This treatment is still years away. But, it is in hot demand and certainly would contribute to making Ariad a more attractive buyout.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up